Further supporting an interaction between BRAF mutation status and CMV, fewer CMV+ patients with BRAF-mutated MM were observed than expected (31 of 92 versus 82 of 153, P = 0.0054, Fisher’s exact test versus BRAF WT; Fig. 6d). This evidence concerns the gene BRAF and Miyoshi myopathy.